Human herpesvirus 4 and adaptive immunity in Alzheimer’s disease
Open Access
- 13 April 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Signal Transduction and Targeted Therapy
- Vol. 5 (1), 1-2
- https://doi.org/10.1038/s41392-020-0125-y
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer’s diseaseNature, 2020
- History and progress of hypotheses and clinical trials for Alzheimer’s diseaseSignal Transduction and Targeted Therapy, 2019
- Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategiesNature Reviews Neurology, 2019
- Alzheimer’s Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain InfectionNeuron, 2018
- Herpes simplex infection and the risk of Alzheimer's disease: A nested case-control studyAlzheimer's & Dementia, 2015
- Herpes virus in Alzheimer's disease: relation to progression of the diseaseNeurobiology of Aging, 2014
- SPECTRUM OF EPSTEIN-BARR VIRUS–ASSOCIATED DISEASESAnnual review of pathology, 2006
- ApoE4 is more efficient than E3 in brain access by herpes simplex virus type 1NeuroReport, 2003
- Age‐Specific Prevalence of Infection with Herpes Simplex Virus Types 2 and 1: A Global ReviewThe Journal of Infectious Diseases, 2002
- APOE -ε4 count predicts age when prevalence of AD increases, then declinesNeurology, 1999